## GRIN1 Protein is a protein. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
GRIN1 encodes the NMDAR1 (NR1) subunit, the essential subunit of N-methyl-D-aspartate (NMDA) receptors. NMDARs are heterotetramers typically composed of two NR1 subunits and two NR2 (A-D) or NR3 subunits.
Key structural features:
- Extracellular domain: Two lobes (S1 and S2) forming the agonist binding domain
- Transmembrane domain: Four helices (M1-M4) forming the ion channel pore
- C-terminal domain: Intracellular tail for signaling interactions
- Glycine/D-serine binding site: NR1 subunit binds the co-agonist
- Magnesium block site: Voltage-dependent Mg2+ block of the channel pore
NMDA receptors are the primary mediators of excitatory synaptic transmission and synaptic plasticity:
- Glutamate binding: Activated by glutamate released from presynaptic terminals
- Co-agonist requirement: Requires glycine or D-serine for activation
- Calcium influx: Highly permeable to Ca2+, triggering intracellular signaling
- Long-term potentiation (LTP): NMDAR activation triggers LTP, the cellular basis of learning
- Long-term depression (LTD): NMDAR-dependent LTD
- Homeostatic plasticity: NMDARs regulate synaptic scaling
- Critical period plasticity: NMDAR subunit composition changes during development
- Synaptogenesis: Required for formation of functional synapses
- Pruning: Involved in activity-dependent synaptic elimination
NMDAR dysregulation is central to excitotoxicity in neurodegenerative diseases:
- Excitotoxicity: Overactivation leads to excessive Ca2+ influx and neuronal death
- Aβ interaction: Aβ oligomers potentiate NMDAR activity
- Synaptic loss: NMDAR overactivation triggers spine elimination
- Tau involvement: Tau facilitates NMDAR internalization
- Excitotoxicity: Dopaminergic neuron loss from excessive glutamate
- Subthalamic nucleus: Hyperactive STN neurons drive motor deficits
- Therapeutic target: NMDAR antagonists (amantadine) improve motor symptoms
- Motor neuron degeneration: NMDAR-mediated excitotoxicity
- Cortical hyperexcitability: Increased NMDAR function in upper motor neurons
- Astrocyte dysfunction: Impaired glutamate uptake increases excitotoxicity
- Ischemic cascade: Energy failure leads to glutamate release and NMDAR overactivation
- Massive calcium influx: Triggers necrotic and apoptotic cell death
- Therapeutic target: NMDAR antagonists have been investigated (limited success)
NMDAR modulators are used for neurodegeneration and neuroprotection:
- Memantine: Low-affinity NMDAR antagonist for AD (moderate benefit)
- Amantadine: NMDAR antagonist for PD and levodopa-induced dyskinesias
- Ketamine: NMDAR antagonist (anesthetic, experimental for depression)
- Ifenprodil: NR2B-selective antagonist
- Rapastinel: NMDAR glycine site modulator
- Anti-NMDAR encephalitis: Immunotherapies target NMDAR autoantibodies